 |
|
If you need to get a quote for any product, or have any questions, please fill in the
following contact form, we will contact you within 24 hours. If your have an account with us, click here to login to retrieve your information.
| Your Contact Information (Required *) |
| First Name* |
|
| Last Name* |
|
| E-Mail* |
|
| Company Name* |
|
| Address |
|
| City |
|
| State |
|
| Zip |
|
| Country |
|
| Phone |
|
| Fax |
|
| Web Site |
|
| |
| Products Interested (Browsing products) |
|
| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0029 |
41870-52-4 |
2-Methylbenzhydryl chloride |
|
| A1-0262 |
324769-07-5 |
1-Boc-2-Ethylpiperidin-4-one |
|
| A1-0265 |
362704-50-5 |
1-Boc-2-tert-Butyl-piperidin-4-one |
|
| A1-0266 |
849928-30-9 |
1-Boc-2-Phenylpiperidin-4-one |
|
| A1-0780 |
31301-51-6 |
2-Chloro-5-Fluoropyridine |
|
| A1-1039 |
352525-94-1 |
(3-Aminomethylphenyl)boronic acid, hydrochloride |
|
| A1-5485 |
N/A |
1-N-Boc-2(S)-Methyl-5(S)-isopropyl piperazine |
|
| A1-6223 |
2018-66-8 |
Cbz-Leu-OH |
|
| AS-3569 |
101827-46-7 |
Butenafine hydrochloride |
|
| AS-5272 |
146162-54-1 |
Bis(2-methyl-8-quinolinolato-N1,O8)-(1,1'-Biphenyl-4-olato)aluminum |
|
| AS-8649 |
535-87-5 |
3,5-Diaminobenzoic acid |
|
| JR6-L1952 |
1213631-49-2 |
Piperidine, 2-(5-chloro-2-methoxyphenyl)-, (2R)- |
|
| JR6-L2601 |
126410-45-5 |
Carbamic acid, N-[(1S)-2-(methoxymethylamino)-2-oxo-1-[[4-(phenylmethoxy)phenyl]methyl]ethyl]-, 1,1-dimethylethyl ester |
|
| JR6-L2703 |
98737-29-2 |
Carbamic acid, N-[(1S)-1-[(2S)-2-oxiranyl]-2-phenylethyl]-, 1,1-dimethylethyl ester |
|
| JR6-L3140 |
75640-69-6 |
1,1'-Binaphthalene, 3,3'-dibromo-2,2'-dimethoxy- |
|
| JR6-L3893 |
891482-18-1 |
2-Pyrrolidinemethanol, a,a-bis[4-(phenylmethoxy)phenyl]-, (2S)- |
|
| JR6-L3985 |
133437-57-7 |
Methanone, (2,3-difluorophenyl)(2-methyl-1H-indol-3-yl)- |
|
| JR6-L3987 |
908336-75-4 |
Benzamide, N-(4-chloro-2-hydroxyphenyl)-2,3-difluoro- |
|
| JR6-L4011 |
120420-99-7 |
4H-Pyrrolo[3,2,1-ij]quinoline, 5,6-dihydro-2-methyl- |
|
| JR6-L4134 |
269396-56-7 |
Benzenebutanoic acid, 3,4-dichloro-ß-[[(1,1-dimethylethoxy)carbonyl]amino]-, (ßR)- |
|
| JR6-L4322 |
887407-52-5 |
N-Succinimidyloxycarbonylpentadecyl Methanethiosulfonate |
|
| JR6-L4599 |
52423-62-8 |
2-BROMO-1-CYCLOPENTYLETHANONE |
|
| JR6-L4687 |
1361551-85-0 |
Spiro[2H,8H-benzo[1,2-b:3,4-b']dipyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4728 |
1241954-09-5 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 5-chloro-3,4-dihydro-3-methyl-4-oxo-, 1,1-dimethylethyl ester |
|
| JR6-L4806 |
936648-36-1 |
Spiro[2H-1-benzopyran-2,4'-piperidine]-1'-carboxylic acid, 3,4-dihydro-4-oxo-6-[(2,2,2-trifluoroacetyl)amino]-, 1,1-dimethylethyl ester |
|
| JR6-L5479 |
1144520-57-9 |
4-Oxazolecarboxylic acid, 2-chloro-5-methyl-, ethyl ester |
|
| JR6-L5483 |
1092465-20-7 |
Oxazole, 2-chloro-4-(4-fluorophenyl)- |
|
| JR6-L5494 |
1019654-82-0 |
Oxazole, 2-iodo-5-phenyl- |
|
| JR6-L5495 |
1007112-35-7 |
4-Benzoxazolecarboxylic acid, 2-chloro-, methyl ester |
|
| JR6-L6755 |
74268-02-3 |
3H-Pyrazol-3-one, 2-[3,5-bis(trifluoromethyl)phenyl]-1,2-dihydro-5-(trifluoromethyl)- |
|
| JR6-L6796 |
122431-40-7 |
1H-Pyrazol-5-ol, 1-(4-nitrophenyl)-3-(trifluoromethyl)- |
|
| JR6-L6867 |
160732-10-5 |
Ethanone, 2-cyclohexyl-1-oxiranyl-, (R)- (9CI) |
|
| JR6-L7105 |
947325-98-6 |
1,2-Ethanediol, 1,2-bis(4-ethoxyphenyl)-, (1S,2S)- |
|
| JR6-L7393 |
1450928-78-5 |
Benzenepropanol, ß-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-methoxy-2-methyl-, (ßS)- |
|
| JR6-L7478 |
1335683-91-4 |
3-Pyridineethanamine, 6-fluoro-a-methyl-, (aR)- |
|
| JR6-L7551 |
1335309-88-0 |
4-Pyridineethanamine, 2,5-dichloro-a-methyl-, (aS)- |
|
| JR6-L7555 |
1335848-64-0 |
4-Pyridineethanamine, 2,5-difluoro-a-methyl-, (aR)- |
|
| JR6-L7672 |
1257122-22-7 |
2-Pyridinemethanamine, 3-fluoro-a-methyl-5-(2,2,2-trifluoroethoxy)-, (aR)- |
|
| JR6-L8034 |
1213517-69-1 |
Benzoic acid, 4-(2R)-2-pyrrolidinyl- |
|
| JR8-N0157 |
58546-55-7 |
Schizandrol B |
|
| JR8-N0649 |
30220-46-3 |
Ingenol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Comments |
| |
|
 |
|
|
|
|
|
|